Back to Search Start Over

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy.

Authors :
Daughety, Molly M.
Morgan, Andrew
Frost, Erin
Kao, Chester
Hwang, Joyce
Tobin, Rachel
Patel, Bhavik
Fuller, Matthew
Welsby, Ian
Ortel, Thomas L.
Source :
Thrombosis Research. Dec2020, Vol. 196, p483-485. 3p.
Publication Year :
2020

Abstract

• COVID-19 patients are at increased risk of thromboembolic complications. • Escalated-dose thromboprophylaxis may help reduce the rate of thromboembolic events. • The bleeding risk is highest for patients treated with therapeutic anticoagulation. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
*COVID-19
*HEMORRHAGE
*THROMBOSIS
*ANTICOAGULANTS

Details

Language :
English
ISSN :
00493848
Volume :
196
Database :
Academic Search Index
Journal :
Thrombosis Research
Publication Type :
Academic Journal
Accession number :
147113748
Full Text :
https://doi.org/10.1016/j.thromres.2020.10.004
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details